$23.97
-0.49-2.00%
At close: -
$24.10
0.130.54%
After Hours: Nov 7, 7:54 PM EDT
Comments
Loading...
Teva Pharmaceutical Indus Earnings Estimates, EPS & Revenue | NYSE:TEVA | Benzinga
Teva Pharmaceutical Indus reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jan 28
EPS Estimate
$0.670
Quarterly Revenue Estimate
$4.41B
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$16.77B
Analyze the earnings history of Teva Pharmaceutical Indus using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
TEVA | Teva Pharmaceutical Indus | $0.71 | $0.67 | — | — | $4.23B | $4.41B | — | — | 01/28/2026 | |
TEVA | Teva Pharmaceutical Indus | $0.69 | $0.67 | $0.78 | 16.42% | $4.33B | $4.34B | $4.48B | 3.20% | 11/05/2025 | |
TEVA | Teva Pharmaceutical Indus | $0.61 | $0.61 | $0.61 | 0.00% | $4.16B | $4.28B | $4.16B | -1.83% | 07/30/2025 | |
TEVA | Teva Pharmaceutical Indus | $0.48 | $0.46 | $0.52 | 13.04% | $3.82B | $3.99B | $3.89B | -2.48% | 05/07/2025 | |
TEVA | Teva Pharmaceutical Indus | $1.00 | $0.70 | $0.71 | 1.43% | $4.46B | $4.12B | $4.23B | 2.65% | 01/29/2025 | |
TEVA | Teva Pharmaceutical Indus | $0.60 | $0.66 | $0.69 | 4.55% | $3.85B | $4.12B | $4.33B | 5.15% | 11/06/2024 | |
TEVA | Teva Pharmaceutical Indus | $0.56 | $0.55 | $0.61 | 10.91% | $3.88B | $4.06B | $4.16B | 2.56% | 07/31/2024 | |
TEVA | Teva Pharmaceutical Indus | $0.40 | $0.51 | $0.48 | -5.88% | $3.66B | $3.73B | $3.82B | 2.39% | 05/08/2024 | |
TEVA | Teva Pharmaceutical Indus | $0.71 | $0.77 | $1.00 | 29.87% | $3.88B | $4.01B | $4.46B | 11.15% | 01/31/2024 | |
TEVA | Teva Pharmaceutical Indus | $0.59 | $0.61 | $0.60 | -1.64% | $3.60B | $3.72B | $3.85B | 3.49% | 11/08/2023 | |
TEVA | Teva Pharmaceutical Indus | $0.68 | $0.52 | $0.56 | 7.69% | $3.79B | $3.71B | $3.88B | 4.53% | 08/02/2023 | |
TEVA | Teva Pharmaceutical Indus | $0.55 | $0.56 | $0.40 | -28.57% | $3.66B | $3.63B | $3.66B | 0.85% | 05/10/2023 | |
TEVA | Teva Pharmaceutical Indus | $0.77 | $0.71 | $0.71 | 0.00% | $4.10B | $3.93B | $3.88B | -1.17% | 02/08/2023 | |
TEVA | Teva Pharmaceutical Indus | $0.59 | $0.62 | $0.59 | -4.84% | $3.89B | $3.83B | $3.60B | -6.14% | 11/03/2022 | |
TEVA | Teva Pharmaceutical Indus | $0.59 | $0.57 | $0.68 | 19.30% | $3.91B | $3.78B | $3.79B | 0.16% | 07/26/2022 | |
TEVA | Teva Pharmaceutical Indus | $0.63 | $0.55 | $0.55 | 0.00% | $3.98B | $3.75B | $3.66B | -2.37% | 05/03/2022 | |
TEVA | Teva Pharmaceutical Indus | $0.68 | $0.73 | $0.77 | 5.48% | $4.45B | $4.29B | $4.10B | -4.43% | 02/09/2022 | |
TEVA | Teva Pharmaceutical Indus | $0.58 | $0.65 | $0.59 | -9.23% | $3.98B | $4.03B | $3.89B | -3.55% | 10/27/2021 | |
TEVA | Teva Pharmaceutical Indus | $0.55 | $0.59 | $0.59 | 0.00% | $3.87B | $4.04B | $3.91B | -3.22% | 07/28/2021 | |
TEVA | Teva Pharmaceutical Indus | $0.76 | $0.59 | $0.63 | 6.78% | $4.36B | $4.02B | $3.98B | -0.95% | 04/28/2021 | |
TEVA | Teva Pharmaceutical Indus | $0.62 | $0.63 | $0.68 | 7.94% | $4.47B | $4.37B | $4.45B | 1.92% | 02/10/2021 |
Teva Pharmaceutical Indus (TEVA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $0.78 | $0.67 | 16.4 % |
| Q2 | 2025-07-30 | $0.61 | $0.61 | 0.00 % |
| Q1 | 2025-05-07 | $0.52 | $0.46 | 13.0 % |
| Q4 | 2025-01-29 | $0.71 | $0.70 | 1.43 % |
Teva Pharmaceutical Indus (TEVA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $4.48B | $4.34B | 3.20 % |
| Q2 | 2025-07-30 | $4.16B | $4.28B | -1.83 % |
| Q1 | 2025-05-07 | $3.89B | $3.99B | -2.48 % |
| Q4 | 2025-01-29 | $4.23B | $4.12B | 2.65 % |
FAQ
When is Teva Pharmaceutical Indus (NYSE:TEVA) reporting earnings?
Teva Pharmaceutical Indus (TEVA) is scheduled to report earnings on January 28, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
What were the latest earnings per share (EPS) for Teva Pharmaceutical Indus (NYSE:TEVA)?
The Actual EPS was $0.78, which beat the estimate of $0.67.
What were Teva Pharmaceutical Indus’s (NYSE:TEVA) revenues?
The Actual Revenue was $4.5B, which beat the estimate of $4.3B.
Browse earnings estimates, EPS, and revenue on all stocks.
